Usage: KEVEYIS is indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and associated variants.
potassium chloride extended-release
(Potassium Chloride)
Sun Pharmaceutical Industries, Inc.
Usage: This drug is indicated for treating hypokalemia, including in cases of digitalis intoxication and familial periodic paralysis. It is also used to prevent hypokalemia in high-risk patients, particularly those with cardiac issues or undergoing diuretic therapy. Potassium salts should be reserved for patients unable to tolerate other forms.